Our understanding of the mechanism of targeted therapies based on NPM1 is still incomplete, and large-scale basic studies are still needed to explore the function and mechanism of NPM1 to provide a new theoretical basis for the treatment of AML. Here, NPM1 is linked to acute myeloid leukemia.